bontyre38.ru aimmune therapeutics stock


Aimmune Therapeutics Stock

AIMT Aimmune Therapeutics Inc ; 26, 0, 0 ; 52, 0, 0 ; , 0, 0 ; , 0, 0. Aimmune Therapeutics Inc is a publicly traded company listed under the ticker symbol Aimmune Therapeutics Inc. Online trading platforms provides real-time. Aimmune Therapeutics · More on Forbes · InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs · Master's Degree In Psychedelics Studies Launches. Aimmune Therapeutics Quote Info ; Support 2, ; Pivot Price, ; Resistance 1, ; Resistance 2, ; Trades, 0. Sorry, the data is not yet available for this stock. Jitta Ranking. HISTORICAL JITTA SCORE.

AIMT Aimmune Therapeutics ; Wk High, $ ; Wk Low, $ Stock Analysis Checklist and DiscoverCI Score ; X, Aimmune Therapeutics Inc's Altman Z Score indicates that this company has a higher chance of filing bankruptcy. Aimmune, Maker of Peanut Allergy Treatment, to Be Bought by Nestle. Nestle will acquire Aimmune, the maker of peanut allergy treatments, in a $ billion deal. To All Holders of Shares of Common Stock of Aimmune Therapeutics, Inc.: INTRODUCTION. SPN MergerSub, Inc., a Delaware corporation (“Purchaser” or “we”) and a. A high-level overview of Aimmune Therapeutics, Inc. (AIMT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Aimmune Therapeutics (AIMT) raised $ million in an IPO on Thursday, August 6th The company issued 8,, shares at $$ per share. BofA. Company profile page for Aimmune Therapeutics Inc including stock price, company news, executives, board members, and contact information. Aimmune Therapeutics Inc Profile, Financial Information, Stock Quotes Charts, Financial Results, Segments, Competitors, Fundamental Analysis - CSIMarket.

Aimmune Therapeutics (AIMT) Overview Currently there is no data available for this company. Intelligent Investor free trial for buy hold sell stock. Aimmune Therapeutics Inc stock price live, this page displays NASDAQ AIMT stock exchange data. View the AIMT premarket stock price ahead of the market session. Get free historical data for AIMT. You'll find the closing price, open, high, low, change and %change of the Aimmune Therapeutics Inc Stock for the selected. Aimmune Therapeutics NASDAQ:AIMT Institutional Own. %. Qtr Updated. 03/30/ Drug Pipeline. Powered. Friday, 27th May AIMT stock ended at $ During the day the stock fluctuated 0% from a day low at $ to a day high of $ 90 days, $ See Aimmune Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Aimmune Therapeutics's post-money. Aimmune Therapeutics, Inc. (bontyre38.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Aimmune Therapeutics. Aimmune Therapeutics, Inc. (AIMT): Price and Financial Metrics ; Market Cap, B ; Merger Arbitrage Analysis And Spread Performance - September 13, We're building a team that aims to transform the lives of patients and their families by developing pharmaceutical therapies to prevent, manage, and treat food.

The Aimmune Therapeutics stock price is USD today. Will AIMT stock price drop / fall? Yes. The Aimmune Therapeutics stock price may drop from USD. Aimmune Therapeutics Stock Signals. NASDAQ Stock Exchange · Open Broker Account. $ +0 (+0%). At Close: May 27, Real-time prices appear during market. Aimmune Therapeutics Inc 's Stock Charts Commodity Channel Index (CCI) technical analysis - CSIMarket. Aimmune Therapeutics, Inc. market cap history and chart from to AIMT was stock price by the number of shares outstanding.

how to make $200 last 2 weeks | us online blackjack

41 42 43 44 45


Copyright 2014-2024 Privice Policy Contacts